Attached files
file | filename |
---|---|
8-K - FORM 8-K - ALKERMES INC | b80194e8vk.htm |
EX-10.1 - EX-10.1 - ALKERMES INC | b80194exv10w1.htm |
Exhibit 10.2
Fiscal 2011 Reporting Officer Performance Pay Plan
Philosophy
We support a pay-for-performance approach to variable compensation that rewards individual and
Company performance towards the achievement of our Company goals. This Plan is designed to provide
upside reward for outstanding Company and individual performance, motivate reporting officers to
focus on and work together toward achieving Company goals; and be competitive within our industry.
Eligibility
Company reporting officers are eligible to participate in the plan. As of April 1, 2010, the
following officers are eligible to participate in the Plan:
| Chief Executive Officer and President and Chairman of the Board of Directors | ||
| Senior Vice President, Chief Financial Officer and Treasurer | ||
| Senior Vice President, Corporate Development | ||
| Senior Vice President, General Counsel and Secretary | ||
| Senior Vice President, Research and Development and Chief Medical Officer | ||
| Senior Vice President, Chief Operating Officer |
The performance period under the Plan consists of the twelve month period from April 1, 2010 to
March 31, 2011. To be eligible to participate in this Plan, the executive officer must be actively
employed by the Company at the time awards are paid by the Company. Performance pay awards will be
paid prior to two and one half months after the end of the performance period.
Individual Performance Pay Targets
An individual performance pay range and target as a percentage of base salary will be established
by the Compensation Committee of the Board of Directors of the Company for each of the reporting
officers and shall be based generally on comparable market data. Performance pay awards are to be
pro-rated based on the number of days employed in the performance period.
Company Objectives
The Company objectives for fiscal 2011 are: (i) maximize revenues from our partnered products, (ii)
prepare for expansion of VIVITROL® business into the opioid indication, (iii) advance our
proprietary pipeline, (iv) expand our portfolio, (v) achieve financial performance against budget
and (vi) respond to changing business conditions.
Individual Performance
Each individuals performance pay award under the Plan will be determined by the Compensation
Committee. Individual performance against the Company objectives affects the determination of each
individuals performance pay award relative to that individuals target performance pay amount. The
CEO of the Company shall provide the Compensation Committee with recommendations regarding the
performance pay for the Senior Vice Presidents. The percentage of base salary represented by each
performance pay award granted under the Plan shall fall within the target performance pay range.
The Compensation Committee reserves the right to modify the Plan, Company objectives or overall
payouts under the Plan at any time during the course of the fiscal year, including in response to
changing business goals, needs and operations.
Approved by the Compensation Committee of the Board of Directors on March 23, 2010